Compare TWST & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | BBWI |
|---|---|---|
| Founded | 2013 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.4B |
| IPO Year | 2018 | 1994 |
| Metric | TWST | BBWI |
|---|---|---|
| Price | $91.19 | $19.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 15 |
| Target Price | ★ $46.88 | $24.88 |
| AVG Volume (30 Days) | 1.5M | ★ 5.2M |
| Earning Date | 05-04-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 4.36% |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ 0.90 |
| Revenue | $376,572,000.00 | ★ $7,291,000,000.00 |
| Revenue This Year | $18.91 | N/A |
| Revenue Next Year | $15.07 | $2.19 |
| P/E Ratio | ★ N/A | $21.49 |
| Revenue Growth | ★ 20.32 | N/A |
| 52 Week Low | $23.30 | $14.28 |
| 52 Week High | $105.47 | $32.32 |
| Indicator | TWST | BBWI |
|---|---|---|
| Relative Strength Index (RSI) | 52.65 | 46.59 |
| Support Level | $86.30 | $18.96 |
| Resistance Level | $105.47 | $21.46 |
| Average True Range (ATR) | 6.31 | 0.91 |
| MACD | -1.21 | -0.21 |
| Stochastic Oscillator | 38.28 | 29.67 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.